The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study

The Lancet Infectious Diseases

Volumn 17, Issue 5, 2017, Pages 491-497

  Imwong, Mallika ^a   Suwannasin, Kanokon ^a   Kunasol, Chanon ^a   Sutawong, Kreepol ^b   Mayxay, Mayfong ^c,d   Rekol, Huy ^f   Smithuis, Frank M ^e,g,h   Hlaing, Tin Maung ⁱ   Tun, Kyaw M ^g,i   van der Pluijm, Rob W ^a,e   Tripura, Rupam ^a   Miotto, Olivo ^a,j   Menard, Didier ^k   Dhorda, Mehul ^l   Day, Nicholas P J ^a,e   White, Nicholas J ^a,e   Dondorp, Arjen M ^a,e  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Amphoe Buntharik   (Thailand)

^c MAHOSOT HOSPITAL   (Laos)

^d UNIVERSITY OF HEALTH SCIENCES   (Laos)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f National Center for Parasitology Entomology And Malaria Control   (Cambodia)

^g Myanmar Oxford Clinical Research Unit   (Myanmar)

^h Medical Action Myanmar   (Myanmar)

ⁱ Department of Social Research Defence Services Medical Research Centre Tatkone Township   (Myanmar)

^j WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^k INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

^l WorldWide Antimalarial Resistance Network   (Thailand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; MICROSATELLITE DNA; PIPERAQUINE; QUINOLINE DERIVATIVE;

ALLELE; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CAMBODIA; CONTROLLED STUDY; GENE; GENE AMPLIFICATION; GENE DOSAGE; GENETIC SIMILARITY; GENETIC VARIABILITY; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HUMAN; LAOS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; MOLECULAR EPIDEMIOLOGY; MULTICENTER STUDY; OBSERVATIONAL STUDY; PFKELCH13 GENE; PFPLASMEPSIN2 GENE; PLASMODIUM FALCIPARUM; POINT MUTATION; PRIORITY JOURNAL; PROPHYLAXIS; THAILAND; DRUG EFFECTS; DRUG RESISTANCE; GENETICS; ISOLATION AND PURIFICATION; MALARIA, FALCIPARUM; MUTATION; PROCEDURES;

ANTIMALARIALS; ARTEMISININS; CAMBODIA; DRUG RESISTANCE; GENOTYPE; HUMANS; LAOS; MALARIA, FALCIPARUM; MICROSATELLITE REPEATS; MOLECULAR EPIDEMIOLOGY; MUTATION; PLASMODIUM FALCIPARUM; QUINOLINES; THAILAND;

EID: 85011304306     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(17)30048-8     Document Type: Article

References (28)

1. 1 WHO. Guidelines for the Treatment of Malaria, 3rd edn. Geneva, 2015.
2. 2 White, NJ, Can new treatment developments combat resistance in malaria?. Expert Opin Pharmacother 17 (2016), 1303–1307.
3. 3 Dondorp, AM, Nosten, F, Yi, P, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 361 (2009), 455–467.
4. 4 Ashley, EA, Dhorda, M, Fairhurst, RM, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 371 (2014), 411–423.
5. 5 Spring, MD, Lin, JT, Manning, JE, et al. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study. Lancet Infect Dis 15 (2015), 683–691.
6. 6 Leang, R, Taylor, WR, Bouth, DM, et al. Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in western Cambodia: dihydroartemisinin-piperaquine open-label multicenter clinical assessment. Antimicrob Agents Chemother 59 (2015), 4719–4726.
7. 7 Phyo, AP, Ashley, EA, Anderson, TJ, et al. Declining efficacy of artemisinin combination therapy against P falciparum malaria on the Thai-Myanmar border (2003–2013): the role of parasite genetic factors. Clin Infect Dis 63 (2016), 784–791.
8. 8 Amaratunga, C, Lim, P, Suon, S, et al. Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. Lancet Infect Dis 16 (2016), 357–365.
9. 9 Takala-Harrison, S, Jacob, CG, Arze, C, et al. Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia. J Infect Dis 211 (2015), 670–679.
10. 10 Miotto, O, Amato, R, Ashley, EA, et al. Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nat Genet 47 (2015), 226–234.
11. 11 WHO. Global Plan for Artemisinin Resistance Containment (GPARC). http://www.who.int/malaria/publications/atoz/9789241500838/en/, 2011 (accessed July 12, 2016).
12. 12 WHO. Strategy for malaria elimination in the Greater Mekong Subregion (2015–2030), 2015, World Health Organization, Geneva.
13. 13 Menard, D, Khim, N, Beghain, J, et al. A worldwide map of Plasmodium falciparum K13-propeller polymorphisms. N Engl J Med 374 (2016), 2453–2464.
14. 14 Wootton, JC, Feng, X, Ferdig, MT, et al. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 418 (2002), 320–323.
15. 15 Roper, C, Pearce, R, Nair, S, Sharp, B, Nosten, F, Anderson, T, Intercontinental spread of pyrimethamine-resistant malaria. Science, 305, 2004, 1124.
16. 16 Witkowski, B, Duru, V, Khim, N, et al. A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study. Lancet Infect Dis, 17, 2017, 174.
17. 17 Amato, RLP, Miotto, O, Amaratunga, C, et al. Genetic markers associated with dihydroartemisinin–piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study. Lancet Infect Dis 17 (2017), 164–167.
18. 18 Tun, KM, Imwong, M, Lwin, KM, et al. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. Lancet Infect Dis 15 (2015), 415–421.
19. 19 Imwong, M, Jindakhad, T, Kunasol, C, Sutawong, K, Vejakama, P, Dondorp, AM, An outbreak of artemisinin resistant falciparum malaria in Eastern Thailand. Sci Rep, 5, 2015, 17412.
20. 20 Cheeseman, IH, Miller, BA, Nair, S, et al. A major genome region underlying artemisinin resistance in malaria. Science 336 (2012), 79–82.
21. 21 Talundzic, E, Okoth, SA, Congpuong, K, et al. Selection and spread of artemisinin-resistant alleles in Thailand prior to the global artemisinin resistance containment campaign. PLoS Pathog, 11, 2015, e1004789.
22. 22 WHO. Genotyping to identify parasite populations, 2008, WHO Press, Geneva.
23. 23 Anderson, TJ, Su, XZ, Bockarie, M, Lagog, M, Day, KP, Twelve microsatellite markers for characterization of Plasmodium falciparum from finger-prick blood samples. Parasitology 119 (1999), 113–125.
24. 24 Malaria GENPfCP. Genomic epidemiology of artemisinin resistant malaria. Elife, 5, 2016, 21.
25. 25 Duru, V, Khim, N, Leang, R, et al. Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations. BMC Med, 13, 2015, 305.
26. 26 Nair, S, Nash, D, Sudimack, D, et al. Recurrent gene amplification and soft selective sweeps during evolution of multidrug resistance in malaria parasites. Mol Biol Evol 24 (2007), 562–573.
27. 27 Imwong, M, Nguyen, TN, Tripura, R, et al. The epidemiology of subclinical malaria infections in South-East Asia: findings from cross-sectional surveys in Thailand-Myanmar border areas, Cambodia, and Vietnam. Malar J, 14, 2015, 381.
28. 28 Tripura, R, Peto, TJ, Chalk, J, et al. Persistent Plasmodium falciparum and Plasmodium vivax infections in a western Cambodian population: implications for prevention, treatment and elimination strategies. Malar J, 15, 2016, 181.